Close Menu

NEW YORK (GenomeWeb) – Baylor Genetics and Rainbow Genomics announced on Monday a partnership to offer clinical exome sequencing tests to patients in Asia.

Hong Kong-based Rainbow Genomics will offer screening and diagnostic exome sequencing-based tests developed by Baylor, including one to assess risk for developing a genetic disorder, a test to assess cancer risk, and a diagnostic cancer test. In addition, Rainbow will use Baylor's Consultagene service to offer bilingual genetic counseling in English, Mandarin, Cantonese, and Japanese.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.